Bandaram Pharma Packtech Board of Directors
Get the latest insights into the leadership at Bandaram Pharma Packtech. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. B Deepak Reddy | Chairman & Managing Director |
| Mr. B Premsai Reddy | Non Executive Director |
| Ms. B Sathyavathi | Non Executive Director |
| Mr. C V S Rajaram | Independent Director |
| Mr. B Suryaprakasa Rao | Independent Director |
| Ms. Priyanka Agarwal | Independent Director |
| Mr. Suman Mallu | Independent Director |
Bandaram Pharma Packtech Share price
BANDARAM
34
2.09 (6.55%)Last updated on 3 Sep, 2025 | 10:49 IST
BUYSELL
Today's High
34.00
Today's Low
32.50
52 Week Low
31.00
52 Week High
63.14
The current prices are delayed, login to your account for live prices
LoginBandaram Pharma Packtech FAQs
The board at Bandaram Pharma Packtech consists of experienced professionals, including Mr. B Deepak Reddy , Mr. B Premsai Reddy , and others, overseeing the company’s strategic and corporate governance.
Directors at Bandaram Pharma Packtech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. B Deepak Reddy is the current chairman at Bandaram Pharma Packtech.
Executive directors at Bandaram Pharma Packtech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Bandaram Pharma Packtech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Bandaram Pharma Packtech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.